Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc., headquartered in Canada, is a prominent player in the pharmaceutical industry, specialising in the development and commercialisation of innovative prescription products. Founded in 2000, the company has achieved significant milestones, including the successful launch of several unique therapies that address unmet medical needs. With a focus on dermatology and pain management, Cipher's core products, such as its proprietary formulations, stand out for their efficacy and patient-centric design. The company has established a strong market position, recognised for its commitment to quality and innovation. Through strategic partnerships and a robust pipeline, Cipher Pharmaceuticals continues to enhance its portfolio, making a meaningful impact in the healthcare landscape.
DitchCarbon Score
How does Cipher Pharmaceuticals Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cipher Pharmaceuticals Inc.'s score of 13 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cipher Pharmaceuticals Inc.'s reported carbon emissions
Cipher Pharmaceuticals Inc., headquartered in Canada, currently does not have available data on its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate commitments. This trend often includes setting science-based targets for emissions reductions and implementing initiatives to enhance energy efficiency and reduce overall carbon footprints. As the industry evolves, Cipher Pharmaceuticals may consider establishing its own climate commitments to align with these emerging standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cipher Pharmaceuticals Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
